PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng East Road, Guangzhou, 510060, China.\', \'State Key Laboratory of Oncology in South China, Guangzhou, 510060, China.\', \'Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.\', \'Department of Hematology, Guangzhou Women and Children\'s Medical Center, Guangzhou Medical University, Guangzhou, 510623, China.\', \'The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA.\', \'National Research Center for Translational Medicine, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, 197, Ruijin Road II, Shanghai, 200025, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.7150/ijbs.51234
?:doi
?:hasPublicationType
?:journal
  • International journal of biological sciences
is ?:pmid of
?:pmid
?:pmid
  • 33061814
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.686
?:rankingScore_hIndex
  • 64
is ?:relation_isRelatedTo_publication of
?:title
  • Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all